Get started
Author

Hobin Yang

Observed names: H Yang, Ho Bin Yang
ORCID: 0000-0002-4913-2763
Observed ORCID: 0000-0002-4913-2763
OpenAlex ID: A5023046525
Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
2014 · S Li, L Li, et al. · British Journal of Cancer · 250
PDF
Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors
2022 · Negesse Mekonnen, Hobin Yang, et al. · Frontiers in Oncology · 121
PDF
Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2–CCR2 signaling
2021 · Shin Ung Kang, Soo Youn Cho, et al. · Laboratory Investigation · 73
Molecular engineering of antibodies for site-specific conjugation to lipid polydopamine hybrid nanoparticles
2020 · Hobin Yang, Quoc-Viet Le, et al. · Acta Pharmaceutica Sinica B · 39
Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse
2022 · Chaithanya Chelakkot, Hobin Yang, et al. · Pharmaceuticals · 19
PDF
Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting
2019 · Hobin Yang, Hayeon Park, et al. · Biomolecules · 17
PDF
The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours
2009 · H Yang, N-H Cho, et al. · Clinical & Experimental Immunology · 14
Selection Strategies and Practical Application of BRAF V600E-Mutated Non–Small Cell Lung Carcinoma
2021 · Inwoo Hwang, Yoon-La Choi, et al. · Cancer Research and Treatment · 12
PDF
Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH
2021 · Kyoung Song, Nirmal Rajasekaran, et al. · Pharmaceuticals · 10
PDF
Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma
2022 · Mi-Sook Lee, Sungbin An, et al. · Cancer Research and Treatment · 9
PDF
Phage Display Technology: Design, Library Construction, and Panning Strategies for Antibody Development
2026 · Hobin Yang · Biomolecules & Therapeutics · 5
Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancer
2024 · Negesse Mekonnen, Hobin Yang, et al. · Translational Oncology · 4
Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer
2022 · Sera Oh, Hobin Yang, et al. · Nuclear Medicine and Biology · 4
Abstract 2118: ABN501: A CLDN3-targeted monoclonal antibody with proven safety, pharmacokinetics, and synergistic anti-tumor efficacy
2025 · Saehyung Lee, Jae Choi, et al. · Cancer Research · 1
Abstract 6010: Evaluation of BsABN501: A novel T cell engager targeting CLDN3-positive solid tumors
2025 · Saehyung Lee, Sangin Lee, et al. · Cancer Research · 1
Design, Screening and Development of Asymmetric siRNAs Targeting the MYC Oncogene in Triple-Negative Breast Cancer
2024 · Negesse Mekonnen, Myeung-Ryun Seo, et al. · Biomolecules & Therapeutics · 1
Abstract 2653: ABN501, a novel anti-claudin-3 antibody, shows potent anti-cancer activity in vitro and in vivo
2023 · Saehyung Lee, Jae Choi, et al. · Cancer Research · 1
Evaluation of the Inhibition of Cytochrome P450 Activity by Ginsenoside Rg5 and Rk1
2026 · Dong won Lee, Mi Jeong Oh, et al. · Die Pharmazie
PDF
Combination strategy of photothermal therapy and targeted IFN-β mutein priming elicits a durable abscopal effect
2026 · Myeung-Ryun Seo, Hee Geon Park, et al. · npj Precision Oncology
PDF
Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer
2026 · Brett A. Schroeder, Jae Choi, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 5237: The significant co-expression of claudin-3(CLDN3) and B7-H3(CD276) as a potential biomarker for targeted therapy in neuroendocrine carcinomas
2026 · Ji-Hye Nam, Ju-Yeon Kim, et al. · Cancer Research
698 Enhancing abscopal effects in colorectal cancer via photothermal therapy combined with Interferon-β
2025 · Myeung Ryun Seo, Jinwon Park, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract 4782: Inducing abscopal effect in colorectal cancer via antibody-conjugated photothermal nanoparticles in combination with immunocytokine
2025 · Myeung Ryun Seo, Jinwon Park, et al. · Cancer Research
Translation Initiation Factor-2S2 (eIF2S2) Contributes to Cervical Carcinogenesis by Inhibiting the TGF-β/SMAD4 Signaling Pathway
2024 · Juthika Kundu, Hobin Yang, et al. · Biomolecules & Therapeutics
Abstract 1863: α-ABN501, a novel antibody targeting claudin-3, demonstrates the potential to be a new therapeutic option for small cell lung cancer
2024 · Jae Choi, Sunghyun Hong, et al. · Cancer Research
Works count: 27
Citation count: 581
H-index: 9
I10-index: 9
Year
Topic
Type